oxymetazoline has been researched along with Apnea, Obstructive Sleep in 2 studies
Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barone, DA | 1 |
| Krieger, AC | 1 |
| Bundrick, JB | 1 |
| Litin, SC | 1 |
2 other studies available for oxymetazoline and Apnea, Obstructive Sleep
| Article | Year |
|---|---|
A 45-Year-Old Man With Delayed Onset of OSA Events During Polysomnography.
Topics: Humans; Male; Middle Aged; Nasal Decongestants; Oxymetazoline; Polysomnography; Rhinitis, Allergic; | 2016 |
Clinical pearls in general internal medicine 2012.
Topics: Abdominal Pain; Administration, Intranasal; Adult; Aged; Atrial Fibrillation; Bone Density; Bronchod | 2013 |